Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model.
暂无分享,去创建一个
J. Tooze | M. Schwarz | R. Cherniack | J. Tooze | T. King | K. R. Brown | K. Brown
[1] A. Nicholson,et al. A histologic pattern of nonspecific interstitial pneumonia is associated with a better prognosis than usual interstitial pneumonia in patients with cryptogenic fibrosing alveolitis. , 1999, American journal of respiratory and critical care medicine.
[2] T. Colby,et al. Idiopathic nonspecific interstitial pneumonia/fibrosis: comparison with idiopathic pulmonary fibrosis and BOOP. , 1998, The European respiratory journal.
[3] J. Myers,et al. Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. , 1998, American journal of respiratory and critical care medicine.
[4] R. Novick,et al. Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease , 1998, The Lancet.
[5] K P Offord,et al. Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. , 1998, American journal of respiratory and critical care medicine.
[6] J A Waldron,et al. Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis. , 1997, American journal of respiratory and critical care medicine.
[7] I. D. Johnston,et al. British Thoracic Society study of cryptogenic fibrosing alveolitis: current presentation and initial management. Fibrosing Alveolitis Subcommittee of the Research Committee of the British Thoracic Society. , 1997, Thorax.
[8] D. Romberger,et al. Cigarette smoke inhibits lung fibroblast proliferation and chemotaxis. , 1995, American journal of respiratory and critical care medicine.
[9] D. Schwartz,et al. Determinants of survival in idiopathic pulmonary fibrosis. , 1994, American journal of respiratory and critical care medicine.
[10] N L Müller,et al. Fibrosing alveolitis: chest radiography and CT as predictors of clinical and functional impairment at follow-up in 26 patients. , 1992, Radiology.
[11] M. Schwarz,et al. The impact of smoking on mechanical properties of the lungs in idiopathic pulmonary fibrosis and sarcoidosis. , 1991, The American review of respiratory disease.
[12] H. Colebatch,et al. Decreased pulmonary distensibility in fibrosing alveolitis and its relation to decreased lung volume. , 1989, Thorax.
[13] M. Schwarz,et al. A clinical, radiographic, and physiologic scoring system for the longitudinal assessment of patients with idiopathic pulmonary fibrosis. , 1986, The American review of respiratory disease.
[14] E. Taskinen,et al. Prognosis of cryptogenic fibrosing alveolitis. , 1983, Thorax.
[15] B. Burrows,et al. Cryptogenic fibrosing alveolitis: response to corticosteroid treatment and its effect on survival , 1980, Thorax.
[16] B. Burrows,et al. Cryptogenic fibrosing alveolitis: clinical features and their influence on survival , 1980, Thorax.
[17] R G Gupta,et al. Natural history and treated course of usual and desquamative interstitial pneumonia. , 1978, The New England journal of medicine.
[18] N. Pride,et al. Lung distensibility. The static pressure-volume curve of the lungs and its use in clinical assessment. , 1976, British journal of diseases of the chest.
[19] R. Forster,et al. A standardized breath holding technique for the clinical measurement of the diffusing capacity of the lung for carbon monoxide. , 1957, The Journal of clinical investigation.
[20] J. H. Comroe,et al. A new method for measuring airway resistance in man using a body plethysmograph: values in normal subjects and in patients with respiratory disease. , 1956, The Journal of clinical investigation.
[21] R. Riley,et al. Ideal alveolar air and the analysis of ventilation-perfusion relationships in the lungs. , 1949, Journal of applied physiology.